Latest Research in Pharmaceutical Economics and Policy

Top Research Topics in Pharmaceutical Economics and Policy

• Pharmaceutical Economics and Policy — 18 papers
• Pharmaceutical Quality and Counterfeiting — 8 papers
• Health Systems, Economic Evaluations, Quality of Life — 8 papers
• Biomedical Ethics and Regulation — 5 papers
• Global Maternal and Child Health — 5 papers
• Biosimilars and Bioanalytical Methods — 4 papers
• Statistical Methods in Clinical Trials — 3 papers
• Infection Control in Healthcare — 3 papers
• Economic and Financial Impacts of Cancer — 2 papers
• Fisheries and Aquaculture Studies — 2 papers

Highest-Cited Papers

1. Operationalization of the African Medicines Agency: Retrospective evaluation of the continental centralized pilot procedure timelines to recommendation and national registrations
2. Advancing Regulatory Adoption of New Approach Methodologies
3. Enhancing access to oral cancer medicines in Lebanon: exploring innovative benefit package designs in private insurance
4. Perspective on Pharmacokinetic Comparability for Biologics Development
5. Lead-time management and supply chain performance in Ugandan public health institutions
6. Development and internal validation of a clinical prediction model for 90-day clinically significant medication-related harm in adults initiating oral anticancer therapy: A multicenter prospective cohort study
7. The Post-Authorisation Maze: Mapping of European Pharmaceutical Market Access Pathways in the Early JCA Era
8. REGULATORY APPROVAL OF IN VITRO DIAGNOSTIC MEDICAL DEVICES IN INDIA: CURRENT FRAMEWORK, REQUIREMENTS, CHALLENGES AND FUTURE PERSPECTIVES
9. When should clinical practice guidelines change? A critical appraisal of the ESVS focused update on paclitaxel-coated devices after SWEDEPAD 2
10. REGULATORY APPROVAL OF IN VITRO DIAGNOSTIC MEDICAL DEVICES IN INDIA: CURRENT FRAMEWORK, REQUIREMENTS, CHALLENGES AND FUTURE PERSPECTIVES
11. Evaluating the Zero-Markup Drug Policy’s Effects on Financial Burden and Pharmaceutical Channel Migration: A Structural Variation and Interrupted Time Series Analysis from Hubei, China
12. Financial Payments From Drug Manufacturers to Oncologists and Use of Guideline-Preferred Cancer Treatments
13. The Medicine Quality Monitoring Globe: A public health intelligence system for collecting and curating reports of substandard and falsified medical products from publicly available Internet news media
14. Identification of key COVID-19 infection contexts over time and the importance of within household infections
15. An explorative approach of the InovSafeCare model for education in infection prevention and control: a cross-sectional study among undergraduate nursing students in sub-Saharan Africa
16. Educational Needs and Educator Competencies of Infection Control Nurses
17. Trends in the Use and Costs of Medications for Respiratory Management Included in the 2022 Benefit Plan of the Colombia Health System
18. Manufacturer-Perceived Development and Market-Entry Risks Associated with Discontinuation and Non-launch of Generic Medicines in Japan: A Cross-Sectional Survey of Marketing Authorization Holders
19. From Compliance to Strategic Partner: The Transformation of Regulatory Affairs in AstraZeneca Local Affiliates
20. Access to essential medicines and vaccines among hard-to-reach populations in Tanzania: evidence from a cross-sectional study of artisanal miners, fisherfolk, and pastoralists